Clinical Trial Update: A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. [Phase 2]

View source ↗

Summary

Ipsen is conducting a Phase 2 study to assess the safety and effectiveness of Elafibranor in adults with Primary Sclerosing Cholangitis, and the trial is active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Elafibranor

Snippet

Sponsor: Ipsen | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING